2020
DOI: 10.1002/ccd.29291
|View full text |Cite
|
Sign up to set email alerts
|

TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more

Abstract: Key Points End stage liver disease (ESLD) is associated with increased risk of bleeding, nosocomial infections and organ failure after open heart surgery. In this study, transcatheter aortic valve replacement (TAVR) was found to have a lower in‐hospital mortality and shorter length of hospital stay as compared with surgical aortic valve replacement (SAVR) in ESLD patients. Broader utilization of transfemoral minimalist TAVR approach might further decrease procedural complications and ameliorate the outcome of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…LT may cause changes in circulating volume due to massive blood loss [ 2 ], needed for transfusion [ 3 ], haemodynamic instability and haemodynamic instability secondary to the ischaemia–reperfusion syndrome [ 4 ]. Patients with left ventricular dysfunction, related to cirrhosis (cirrhotic cardiomyopathy) [ 5 ] or with clinically relevant valvulopathies [ 6 ] or history of coronary artery disease (CAD) have an increased risk of morbidity and mortality both in the peri- and post-operative phases of LT [ 7 ]. Pre-existent CAD worsens the early surgical outcome [ 8 ] and raises mortality after LT [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…LT may cause changes in circulating volume due to massive blood loss [ 2 ], needed for transfusion [ 3 ], haemodynamic instability and haemodynamic instability secondary to the ischaemia–reperfusion syndrome [ 4 ]. Patients with left ventricular dysfunction, related to cirrhosis (cirrhotic cardiomyopathy) [ 5 ] or with clinically relevant valvulopathies [ 6 ] or history of coronary artery disease (CAD) have an increased risk of morbidity and mortality both in the peri- and post-operative phases of LT [ 7 ]. Pre-existent CAD worsens the early surgical outcome [ 8 ] and raises mortality after LT [ 9 ].…”
Section: Introductionmentioning
confidence: 99%